biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Bioasis Connections

<< Previous

Bullboard Posts

Next >>

Comment by JDavenporton Jun 26, 2022 7:59pm

184 Views

Post# 34783527

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Bioasis Connections

I once said on this forum that if I ever went rogue, I could make cases for a lot of things that would put the usual trolls to shame. They don't know enough to be effective. I do.

After 14 years, over three of them with DrDR, we're at18¢, and this year, which is half over, is going to be great, they say. It could be true, but 18¢ says that people don't believe it and that is a function of poor messaging and deals that have not been received with any enthusiasm. I contend that the lack of enthusiasm and confidence is because of a story poorly told.

jd

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages